Pan, Deng <br/><br/>
Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.  [electronic resource] 

 -  Japanese journal of clinical oncology  Feb 2015 
 - 202-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-3621 
<br/><br/><label>Standard No.: </label>10.1093/jjco/hyu194  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--analysis<br/>Carcinoma, Renal Cell--chemistry<br/>China<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Kidney Neoplasms--chemistry<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--diagnosis<br/>Neoplasm Staging<br/>Nephrectomy--methods<br/>Prognosis<br/>Proportional Hazards Models<br/>Receptors, Interleukin-11--analysis<br/>Retrospective Studies<br/>Tissue Array Analysis<br/>Treatment Outcome